Overview
Lorenzo Gualco practices practicing medicine in Genoa, Italy.
His clinical expertise encompasses Cerebral Amyloid Angiopathy, Alzheimer's Disease, and Primary Amyloidosis.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lorenzo Gualco
Is Lorenzo Gualco a top-rated expert for Cerebral Amyloid Angiopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Lorenzo Gualco is classified as an Experienced expert for Cerebral Amyloid Angiopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lorenzo Gualco participate in research or clinical trials?
Yes. Lorenzo Gualco has published 11 articles and abstracts on conditions like Cerebral Amyloid Angiopathy. You can view a list of Lorenzo Gualco's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alzheimer's DiseaseMr. Gualco isExperienced. Learn about Alzheimer's Disease.
- Cerebral Amyloid AngiopathyMr. Gualco isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Primary AmyloidosisMr. Gualco isExperienced. Learn about Primary Amyloidosis.